CONCLUSION: This study revealed that endolymphatic hydrops (EH) reduced in some cases with @entity195 ( @entity601 ) treated conservatively. It appears that the EH reduction was associated with improvement of the clinical symptoms. OBJECTIVES: The relationship between the degree of EH and clinical symptoms is not clear at present. The purpose of the present study was to investigate the time course of the relationship in @entity1 with @entity601 treated conservatively. @entity1 : Twelve @entity1 with @entity601 treated conservatively for more than 1 year in a university hospital. METHODS: Twenty ears of 12 @entity1 with @entity601 treated conservatively were evaluated. The presence or absence of vertigo, @entity2169 was confirmed when magnetic resonance imaging (MRI) was performed. Using a 3 T MRI scanner, three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) MRI was performed 2 or 3 times 24 hours after intra-tympanic @entity2287 injection or 4 hours after intravenous @entity2287 injection. RESULTS: In the three ears in which the symptoms alleviated, EH was reduced in two ears, but EH was reduced in only one of 17 ears in which the symptoms did not alleviate. The Fisher exact test revealed that EH reduction occurred more frequently in ears with alleviation of the symptoms (p < 0.05).

Changes in endolymphatic hydrops in @entity1 with XXXX treated conservatively for more than 1 year.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity601 :: ('MESH:D009436', 'Disease') :: ['MD'] @entity195 :: ('MESH:D000544', 'Disease') :: ["M  ni  re's disease"] @entity2169 :: ('MESH:D004427', 'Disease') :: ['tinnitus and ear fullness'] @entity2287 :: ('MESH:D005682', 'Chemical') :: ['gadolinium']
@entity195 :: (MESH:D000544,Disease) :: ['M  ni  re's disease']
